Duchenne Muscular Dystrophy (DMD) In Vitro Assay Service

Duchenne Muscular Dystrophy (DMD) presents a significant challenge to researchers seeking effective therapies. At Creative Biolabs, we understand the urgency and complexity of this disease. That's why we offer a comprehensive suite of cutting-edge in vitro, in vivo, and ex vivo assays designed to provide unparalleled insights into DMD's intricate mechanisms. Partner with Creative Biolabs and leverage our advanced platforms to drive your research forward. Contact us today to learn how we can support your DMD research goals.

Available Models Available Assays

Available In Vitro Models

Fig. 1 DMD patient-derived iPSCs. Fig.1 DMD patients' iPSCs.¹

Cell models	Details
DMD Patient-Derived iPSCs	Our induced pluripotent stem cell (iPSC)-derived skeletal muscle differentiation model offers a robust and reliable platform for disease modeling and drug discovery. Using healthy or patient-derived iPSCs, we generate functional skeletal muscle fibers that accurately mimic disease phenotypes. This system enables personalized research strategies and high-throughput screening, while providing a consistent and stable cell source, reducing dependence on traditional animal models.
3D iPSC-Derived Skeletal Muscle Model	Our 3D human pluripotent stem cell-derived skeletal muscle model offers an unparalleled platform for studying DMD and other muscle disorders. By generating complex 3D muscle tissue from human pluripotent stem cells, we accurately replicate key pathological features like muscle fiber degeneration and functional abnormalities, mirroring human muscle physiology more closely than traditional models. The integration of tissue engineering, machine learning, and electrical stimulation enables dynamic monitoring of muscle contraction, significantly optimizing drug screening and mechanism research.
Neuromuscular Circuit Model	Our patient iPSC-derived neuromuscular microphysiological model allows for precise control of muscle contraction via optogenetics. This system reveals the impact of DMD on the neuromuscular junction (NMJ), demonstrating that inhibiting TGFβ signaling can partially restore motor function. It offers a novel platform for studying neuromuscular interactions and developing targeted therapies.

Available DMD In Vitro Assays

Gain deeper insights into DMD with our comprehensive in vitro assay panel. Our assays deliver crucial readouts, including:

Cell Viability Analysis: Determine the impact of treatments on muscle cell survival.
Myotube Formation Analysis: Assess the ability of myoblasts to differentiate and form functional muscle fibers.
Creatine Kinase (CK) Release Analysis: Quantify muscle damage through precise CK measurement.
Contractile Function Analysis: Evaluate muscle strength and endurance using advanced techniques.
Dystrophin Expression Analysis: Measure dystrophin protein levels to assess gene therapy efficacy.
Inflammatory Markers Analysis: Analyze inflammatory responses in muscle tissue.

Accelerate your DMD research with our specialized CRO services. Leveraging state-of-the-art 3D in vitro models, we provide comprehensive testing solutions designed to drive breakthroughs from fundamental mechanism studies to effective drug development. Our advanced platforms deliver precise, physiologically relevant data, enabling you to optimize your therapeutic strategies. Contact us today to develop a customized service plan tailored to your specific research needs and accelerate your path to impactful discoveries.

Reference

Budzińska, Marta, et al. "In Vitro Gene Therapy Using Human iPS-Derived Mesoangioblast-Like Cells (HIDEMs) Combined with Microdystrophin (μDys) Expression as the New Strategy for Duchenne Muscular Dystrophy (DMD) Experimental Treatment." International Journal of Molecular Sciences 25.22 (2024): 11869. Distributed under Open Access license CC BY 4.0, without modification.

For Research Use Only. Not For Clinical Use.

In Vitro Services

Hot Products

Antibodies

Cells

Kits

Tracers

Gene Therapy Tools

Biospecimens

Cell Assay Reagents